TME Pharma Publishes Its Semi Annual Results and Half-Year Report
Filed with Euronext · · 3 pages · English
Summary by 6ix AI
TME Pharma N.V. has published its semi-annual results and half-year report, detailing its financial performance for the first half of the year. The report indicates no revenue and a net loss, with significant reductions in general and administrative and research expenses. The CEO emphasized the focus on partnerships and cost control, highlighting the potential benefits from the exclusivity agreement with TMS.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from TME Pharma
- TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
- TME Pharma extends financial visibility by lengthening debt maturity to June 2028
- TME Pharma CEO message
- Message du CEO de TME Pharma
- TME Pharma fait le point sur ses activités
Later from TME Pharma
All TME Pharma news releasesFollow TME Pharma into a list and get an email when it puts out news.
Follow TME Pharma